THRN News and Press, Thorne Healthtech Inc. From 07/21/23

2023-07-21 11:24:32 ET Thorne HealthTech ( NASDAQ: THRN ) jumped 17% amid a report that the provider of at-home health tests is exploring a sale. Thorne ( THRN ) is working with investment bank CG Sawaya Partners as it explores interest from strategic buyers and privat...

2023-06-23 08:13:16 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips The conventional definition of a penny stock is one that trades below $1. However, it’s more common to define a penny stock as any stock that trades for less than $5. These stocks carr...

2023-06-19 08:43:50 ET Summary The nutraceuticals industry is expected to experience moderate growth, with Thorne well-positioned to capture higher-end segments. Thorne's focus on R&D, innovations, and strong direct-to-consumer sales contribute to its potential for moderate up...

Thorne HealthTech's At-Home Blood Sampling Device - NanoDrop - Earns CE Mark Certification in the European Union PR Newswire NEW YORK , June 15, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne") (NASDAQ: THRN), a leader in delivering innovative solutio...

Thorne HealthTech to Participate in TD Cowen's 7th Annual Future of the Consumer Conference on June 7 PR Newswire NEW YORK , May 30, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne") (the "Company") (NASDAQ: THRN ), a leader in delivering innovative sol...

2023-05-15 08:58:54 ET Thorne HealthTech ( NASDAQ: THRN ) is experiencing a 5.2% increase in premarket trading following its recent collaboration announcement. The company entered into a research and development partnership agreement with Arome Science, a metabolomics data...

Thorne HealthTech Enters into Research and Development Partnership with Arome Science to Develop Next-Generation Metabolomics Test PR Newswire NEW YORK , May 15, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne") (NASDAQ: THRN ), a leader in delivering i...

2023-05-11 16:41:28 ET Thorne HealthTech press release ( NASDAQ: THRN ): Q1 Non-GAAP EPS of $0.06 misses by $0.01 . Revenue of $65.24M (+20.7% Y/Y) misses by $0.96M . 2023 Outlook: Net sales $280 million - $290 million, Adjusted EBITDA $30 million - $32 mil...

Thorne HealthTech Reports First Quarter 2023 Results PR Newswire Net Sales Growth of 20.7%; Reaffirms Full-Year 2023 Guidance NEW YORK , May 11, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne HealthTech", "Thorne" or the "Company") (NASDAQ: ...

Thorne HealthTech to Participate in the 2023 RBC Capital Markets Global Healthcare Conference on May 16 PR Newswire NEW YORK , May 3, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne") (the "Company") (NASDAQ: THRN), a leader in delivering innovative so...